Page 145 - 《中国药房》2026年1期

[ 3 ] OH P J，LEE J R，KIM S K，et al. Changes in ronal uptake transporters contribute to oxaliplatin neuro‐
chemotherapy-induced peripheral neuropathy，disturbance toxicity in mice[J]. J Clin Invest，2020，130（9）：4601-
in activities of daily living，and depression following che‐ 4606.
motherapy in patients with colorectal cancer：a prospec‐ [17] YI Y D，LI L P，SONG F F，et al. L-tetrahydropalmatine
tive study[J]. Eur J Oncol Nurs，2020，44：101676. reduces oxaliplatin accumulation in the dorsal root gang-
[ 4 ] ZHANG C Y，XU C，GAO X Y，et al. Platinum-based lion and mitochondria through selectively inhibiting the
drugs for cancer therapy and anti-tumor strategies[J]. Thera- transporter-mediated uptake thereby attenuates peripheral
nostics，2022，12（5）：2115-2132. neurotoxicity[J]. Toxicology，2021，459：152853.
[ 5 ] VALÉRY M，TANGUY M L，GELLI M，et al. Oxaliplatin- [18] 鲁琼，朱海宏，戚听听，等. OCTN2 基因多态性影响结直
induced peripheral neuropathy with hepatic arterial versus 肠癌奥沙利铂化疗敏感性[J]. 中国临床药理学与治疗
intravenous infusion in metastatic colorectal cancer[J]. 学，2021，26（4）：401-407.
Support Care Cancer，2024，32（10）：660. [19] 陈佳音，王丽，王立军，等. 有机阳离子转运体基因多态
[ 6 ] 刘素，张侠. 奥沙利铂神经毒性机制及基因多态性研究 性与奥沙利铂毒性及疗效的相关性研究[J]. 中国临床药
进展[J]. 中华临床医师杂志，2015，9（9）：1685-1689. 理学与治疗学，2022，27（2）：171-177.
[ 7 ] TAÏB S， DURAND J， BRUNET I. Neuropathie [20] VARGAS-ALIAGA A，DE LA HABA M，CONTRERAS
périphérique induite par l’oxaliplatine：comment faire M J，et al. NeuroPredict：study of the predictive value of
barrière?[J]. Médecine，2020，36：33-37. ABCB1 genetic polymorphisms and associated clinical
[ 8 ] BABACAN A. Cold-associated laryngopharyngeal dyses‐ factors in chronic chemotherapy-induced peripheral neu‐
thesia syndrome after oxaliplatin treatment[J]. J Oncol ropathy （CIPN）[J]. Front Pharmacol，2024，15：1352939.
Pharm Pract，2024，30（7）：1245-1248. [21] DIONISI M，RIVA B，DELCONTI M，et al. Inhibition of
[ 9 ] BRANCA J J V，CARRINO D，GULISANO M，et al. NHE1 transport activity and gene transcription in DRG
Oxaliplatin-induced neuropathy：genetic and epigenetic neurons in oxaliplatin-induced painful peripheral neuro‐
profile to better understand how to ameliorate this side ef‐ toxicity[J]. Sci Rep，2023，13（1）：3991.
fect[J]. Front Mol Biosci，2021，8：643824. [22] KIM W，CHO Y A，KIM D C，et al. Association between
[10] KAWASHIRI T，MINE K，KOBAYASHI D，et al. Thera‐ genetic polymorphism of GSTP1 and toxicities in patients
peutic agents for oxaliplatin-induced peripheral neuropa‐ receiving platinum-based chemotherapy：a systematic re‐
thy； experimental and clinical evidence[J]. Int J Mol Sci， view and meta-analysis[J]. Pharmaceuticals （Basel），
2021，22（3）：1393. 2022，15（4）：439.
[11] TENG C，COHEN J，EGGER S，et al. Systematic review [23] CERPA L C，SANDOVAL C，ESCALANTE P，et al. Ge‐
of long-term chemotherapy-induced peripheral neuropathy netic variants and clinical determinants affecting the re‐
（CIPN） following adjuvant oxaliplatin for colorectal can‐ sponse to 5-fluorouracil-based treatment in Chilean pa‐
cer[J]. Support Care Cancer，2022，30（1）：33-47. tients with advanced colorectal cancer[J]. Front Oncol，
[12] EGASHIRA N. Pathological mechanisms and preventive 2025，15：1589724.
strategies of oxaliplatin-induced peripheral neuropathy[J]. [24] CHEN Y C，TZENG C H，CHEN P M，et al. Influence of
Front Pain Res （Lausanne），2021，2：804260. GSTP1 I105V polymorphism on cumulative neuropathy
[13] IBRAHIM E Y， EHRLICH B E. Prevention of and outcome of FOLFOX-4 treatment in Asian patients
chemotherapy-induced peripheral neuropathy：a review of with colorectal carcinoma[J]. Cancer Sci，2010，101（2）：
recent findings[J]. Crit Rev Oncol Hematol，2020，145： 530-535.
102831. [25] 曲珍，徐圣秋，王轩 . GSTP1 基因多态性与结直肠癌患
[14] NICHETTI F，FALVELLA F S，MICELI R，et al. Is a 者奥沙利铂化疗敏感性及周围神经毒性的关系[J]. 肿瘤
pharmacogenomic panel useful to estimate the risk of 药学，2023，13（4）：449-454.
oxaliplatin-related neurotoxicity in colorectal cancer pa‐ [26] PUERTA-GARCÍA E，URBANO-PÉREZ D，CARRASCO-
tients?[J]. Pharmacogenomics J，2019，19（5）：465-472. CAMPOS M I，et al. Effect of DPYD，MTHFR，ABCB1，
[15] GALLUCCIO M，TRIPICCHIO M，POCHINI L. The hu‐ XRCC1，ERCC1 and GSTP1 on chemotherapy related
man OCTN sub-family：gene and protein structure，expres‐ toxicity in colorectal carcinoma[J]. Surg Oncol，2020，35：
sion，and regulation[J]. Int J Mol Sci，2024，25（16）：8743. 388-398.
[16] HUANG K M，LEBLANC A F，UDDIN M E，et al. Neu‐ [27] VELASCO R，ALEMANY M，VILLAGRÁN M，et al.

中国药房 2026年第37卷第1期 China Pharmacy 2026 Vol. 37 No. 1 · 135 ·